Statin use and risk of pancreatic cancer: a meta-analysis

Cancer Causes & Control : CCC
Xiaobing CuiBo Jiang

Abstract

Statins are commonly prescribed medications that potently reduce cholesterol levels and the risk of cardiovascular events. Preclinical studies suggested statins also possess cancer chemopreventive properties. However, the clinical studies provided contradictory results as to whether statins influence the risk of pancreatic cancer. Herein, we present this meta-analysis to assess the association between statin use and risk of pancreatic cancer. We conducted a comprehensive search up to August 2011 for the eligible studies. Pooled relative risk (RR) estimates and corresponding 95 % confidence intervals (CIs) were calculated using the inverse-variance-weighted random-effects model. Subgroup analyses were conducted where data were available. Heterogeneity was assessed by the Cochran's Q test and the I(2) statistic. We included 16 studies that involving 1,692,863 participants and 7,807 pancreatic cancer cases. Pooled results only indicated a non-significant decrease of pancreatic cancer risk among all statin users (RR 0.89; 95 % CIs, 0.74-1.07). Similar results were obtained in the subgroup analyses of the long-term (more than 4 years) follow-up (RR 0.94, 0.81-1.08) and statin use (RR 0.97, 0.76-1.23), and a null association was foun...Continue Reading

References

Sep 11, 1992·Gastroenterology·S SumiJ C Thompson
Apr 1, 1994·Medical Decision Making : an International Journal of the Society for Medical Decision Making·A S MidgetteS G Pauker
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Apr 14, 1999·Journal of Clinical Epidemiology·J H OlsenJ F Fraumeni
Feb 9, 2000·Pharmacology & Therapeutics·A CorsiniF Bernini
Jan 10, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D HaguenauerG Wells
Jun 22, 2002·JAMA : the Journal of the American Medical Association·Patrick W J C SerruysUNKNOWN Lescol Intervention Prevention Study (LIPS) Investigators
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Feb 5, 2004·British Journal of Cancer·J A Kaye, H Jick
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthijs R GraafHenk-Jan Guchelaar
Aug 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Robin E DuncanMichael C Archer
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Krista M DaleC Michael White
Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jim DimitroulakosGlenwood Goss
Jan 20, 2007·Epidemiology·Patricia F CooganBrian L Strom
Feb 16, 2007·Epidemiology·Patricia G Moorman, Robert J Hamilton
Oct 19, 2007·Pharmacoepidemiology and Drug Safety·Gary D FriedmanLaurel A Habel
Nov 22, 2007·International Journal of Cancer. Journal International Du Cancer·Helena GbelcováLibor Vítek
Aug 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jaana KuoppalaEero Pukkala
Jan 29, 2009·The American Journal of Gastroenterology·Libor Vítek
Feb 21, 2009·Current Atherosclerosis Reports·Alawi A Alsheikh-Ali, Richard H Karas
Apr 17, 2009·The Cochrane Database of Systematic Reviews·Jill FerrariTrevor D Prior
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Sep 10, 2009·International Journal of Cancer. Journal International Du Cancer·Jari HaukkaJari Tiihonen
Apr 10, 2010·Expert Opinion on Drug Safety·Denise M BoudreauJeanene Johnson
Apr 30, 2010·The New England Journal of Medicine·Manuel Hidalgo
Jul 28, 2010·Gut·Marc BardouMyriam Martel
Aug 11, 2010·Cancer Causes & Control : CCC·Marie C BradleyLiam J Murray
Feb 1, 2011·Pharmacology & Therapeutics·Christos VaklavasApostolia Maria Tsimberidou
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Jun 12, 2013·European Journal of Clinical Pharmacology·Xiao-Dan WuYan-Qing Chen
Oct 1, 2013·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Volker FendrichJens Waldmann
Nov 6, 2013·Gastroenterología y hepatología·José Lariño Noia
Oct 2, 2013·Nature Reviews. Clinical Oncology·Naomi Gronich, Gad Rennert
Mar 8, 2013·PloS One·Min TanChanghui Wang
Jan 8, 2014·Current Atherosclerosis Reports·William J Kostis
Nov 23, 2013·Cancer Causes & Control : CCC·Yanqiong LiuXue Qin
Apr 20, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Francesco SalvoAntoine Pariente
Dec 7, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J P A IoannidisA N Freedman
Mar 8, 2014·World Journal of Gastroenterology : WJG·Julian SwierczynskiTomasz Sledzinski
Aug 25, 2015·International Journal of Cancer. Journal International Du Cancer·Mei-Jyh ChenPau-Chung Chen
Jul 25, 2013·British Journal of Clinical Pharmacology·Xiao-long ZhangYan Wu
Jul 22, 2015·The American Journal of Gastroenterology·Bechien U WuRobert M Cooper
Jan 22, 2015·Oncology Reports·Abdullah K Altwairgi
Dec 17, 2014·International Journal of Epidemiology·Patrick Maisonneuve, Albert B Lowenfels
May 14, 2016·Medicine·Hee Seung LeeSeungmin Bang
Aug 20, 2016·Archives of Toxicology·Elisa BaroneStefano Landi
Sep 18, 2014·BMJ Open·Meng ShiXiaobing Cui
Jan 10, 2017·International Journal of Molecular Sciences·Elena ArrigoniAntonello Di Paolo
Mar 10, 2017·Scientific Reports·Helena GbelcováLibor Vítek
Jan 25, 2018·Journal of Gastroenterology·Tsuyoshi HamadaBrian Matthew Wolpin
Feb 9, 2018·Internal and Emergency Medicine·Anna LicataMaurizio Soresi
Mar 13, 2019·International Journal of Cancer. Journal International Du Cancer·Jakob KirkegårdDeirdre Cronin-Fenton
Jun 12, 2019·Journal of Clinical Medicine·Gwang Hun JeongGabriele Gamerith
Jun 19, 2015·Physiological Reviews·Emily Jane Gallagher, Derek LeRoith
Apr 30, 2017·Oncology Letters·Jun GongMonica M Mita
Jan 11, 2019·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Shyam Menon, Ray Mathew
Jan 11, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sara ZaniniGiovanna Bermano
Nov 30, 2020·Seminars in Cancer Biology·Giovanna RevillaJoan Carles Escolà-Gil
May 1, 2021·Journal of Clinical Medicine·Maria J Monroy-IglesiasAida Santaolalla

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Causes & Control : CCC
Xiao-long ZhangJun-hua Zheng
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
Danitza PradelliGiovanni Corrao
World Journal of Gastroenterology : WJG
Meng-Hsuan ChengChun-Yuh Yang
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Meng-Hsuan ChengChun-Yuh Yang
© 2021 Meta ULC. All rights reserved